Long-term Study of ASP1941 - Study to Assess the Efficacy and Safety of ASP1941 in Patients With Type 2 Diabetes Mellitus Who Have Renal Impairment.
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2015
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Diabetic nephropathies; Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 29 Feb 2012 Actual patient number added 165 according to ClinicalTrials.gov.
- 29 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.